THOMAS G WIGGANS
CIK 1208907 · Chief Executive Officer · last filed 2025-09-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.48M
Companies
9
Total Filings
111
Lifetime Open-Market Net
-$7.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | Director | 46,000 | $0.01 | $616 | $130.7K | 7 | 2025-09-24 |
| ANNX | Director | — | $4.71 | — | $0 | 5 | 2025-06-09 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 5 | 2024-03-22 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Chief Executive Officer | 0 | $2.16 | $0 | $53.0K | 6 | 2023-08-31 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 4 | 2022-10-14 |
| DERM | CEO & Chairman of the Board | 233,506 | $6.34 | $1.48M | -$5.33M | 40 | 2019-08-19 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | Director | 8,115 | — | — | -$2.07M | 19 | 2013-05-23 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 122,287 | — | — | -$80.9K | 13 | 2012-07-03 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | — | $0.18 | — | $0 | 4 | 2011-06-03 |
Recent Filings · Page 3 of 12
111 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-09 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2022-03-04 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +2,750 | $0 | EDGAR |
| 2021-06-04 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-09 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-24 | — | Mixed | −257,948 | -$4.33M | |
| 2019-08-19 | DERM | Mixed | +31,274 | $100.0K | EDGAR |
| 2019-02-14 | DERM | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.